Abstract:Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Sirt3, a member of the family of nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylases, mainly localizes at mitochondria and participates in regulation of multiple cellular processes through its effect on protein acetylation. In recent years, the role of protein acetylation in controlling autophagy, a process of self-degradation of cellular components in response to various stresses such as starvation and oxidative stress, has begun to emerge. The objective of this study was to determine whether Sirt3, as a mitochondrial deacetylase, affects the induction of mitochondrial autophagy (mitophagy), a process of the specific autophagic elimination of damaged mitochondria. In human glioma cell lines T98G and LN229 and breast cancer cell lines MCF-7 and MDAMB468, we showed that increased production of reactive oxygen species (ROS) and damaged mitochondria (decreased mitochondrial membrane potential, MMP) caused by hypoxia were accompanied by activation of autophagy, as evidenced by elevated amounts of LC3 II, Atg5 and Atg12-5 complex that were detected by western blot. Silencing of Sirt3 expression by RNA interference blunted the hypoxia-induced autophagic response, blocked the degradation of mitochondria marker COX IV, and further increased the accumulation of ROS, suggesting an involvement of this protein deacetylase in the induction of mitophagy. Silencing of Sirt3 expression also promoted apoptosis, as demonstrated by an increase in the population of tumor cells with Annexing V staining and by a reduction in MMP. Furthermore, our experiments showed that silencing of Sirt3 expression led to a down-regulation of the anti-apoptotic proteins mcl-1 and survivin, and MG132, a proteasome inhibitor, could rescue the down-regulation of these apoptosis-regulated proteins in the cells with silencing of Sirt3 expression. These results suggest that Sirt3 plays a role in stabilizing mcl-1 and survivin proteins, and that the down-regulation of mcl-1 and survivin by Sirt3 knockdown may account for the promotion of apoptosis in the cells treated with Sirt3-targeted siRNA. Similarly observations were made when these cell lines were subjected to starvation and oxidative stress (H2O2 treatment). Taken together, the results of the current study reveal Sirt3 as a novel regulator coupling mitophagy and apoptosis, two important cellular processes that determine survival and death of tumor cells. As alterations of mitophagy and apoptosis have been known to be associated with tumor development, progression, and therapy, our study on the role of Sirt3 in regulating these two cellular processes provides evidence for exploiting Sirt3 as a new drug target for prevention and treatment of cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 4106. doi:1538-7445.AM2012-4106

Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia.

Abstract 4106: Sirt3 controls the switch between mitophagy and apoptosis in tumor cells

Interaction of Sirt3 with OGG1 Contributes to Repair of Mitochondrial DNA and Protects from Apoptotic Cell Death under Oxidative Stress

Sirtuin 3 induces apoptosis and necroptosis by regulating mutant p53 expression in small‑cell lung cancer.

Autophagy Maintains Ubiquitination-Proteasomal Degradation of Sirt3 to Limit Oxidative Stress in K562 Leukemia Cells

Sirt3 enhances glioma cell viability by stabilizing Ku70-BAX interaction

SIRT3 Participates in Glucose Metabolism Interruption and Apoptosis Induced by BH3 Mimetic S1 in Ovarian Cancer Cells.

SIRT1 Protects Against Apoptosis by Promoting Autophagy in the Oxygen Glucose Deprivation/Reperfusion-Induced Injury.

Sirt3 is a tumor suppressor in lung adenocarcinoma cells.

Sirt3 Activates Autophagy to Prevent DOX-induced Senescence by Inactivating PI3K/AKT/mTOR Pathway in A549 Cells.

Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway.

Sirt3 Is A Mitochondrial Tumor Suppressor: A Scientific Tale That Connects Aberrant Cellular Ros, The Warburg Effect, And Carcinogenesis

Sirt3 Overexpression Inhibits Growth Of Kidney Tumor Cells And Enhances Mitochondrial Biogenesis

SIRT 3 Enhances Glycolysis and Proliferation in SIRT 3-Expressing Gastric Cancer Cells

SIRT3 Regulates Cell Proliferation and Apoptosis Related to Energy Metabolism in Non-Small Cell Lung Cancer Cells Through Deacetylation of NMNAT2.

Radiation resistance of cancer cells caused by mitochondrial dysfunction depends on SIRT3-mediated mitophagy

SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells

Sirt3 Protects Retinal Pigment Epithelial Cells From High Glucose-Induced Injury by Promoting Mitophagy Through the AMPK/mTOR/ULK1 Pathway

SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.

Silent information regulator 3 modulates lysosome function to inhibit apoptosis of U87 cell by mTOR pathway

Advances in SIRT3 involvement in regulating autophagy-related mechanisms